title: CD47 and TLR-2 cross-talk regulates neutrophil transmigration.
abstract: Neutrophil (PMN) infiltration into tissues is a hallmark of acute inflammation and is crucial for the rapid removal of microbial pathogens. Previous studies have shown that PMN transmigration is regulated by the cell surface protein CD47. However this phenomenon in the context of microbial invasion and subsequent TLR signaling is poorly understood. In this study, we assessed the role of TLR2 and CD47 costimulation in regulating PMN transmigration. Human PMN transmigration across acellular collagen-coated filters toward the bacterial chemoattractant fMLP was more significantly inhibited by MALP-2 (TLR2/6 agonist) than Pam(3)CSK(4) (TLR2/1 agonist). Subsequent experiments demonstrated that treatment with MALP-2 or anti-human CD47 mAbs delayed human PMN transfilter migration, while combined treatment led to further delayed inhibition. Interestingly, stimulation of PMNs with MALP-2 resulted in an increase in surface expression of CD11b, but not CD47. In experiments addressing the role of TLR agonists in regulating CD47-mediated PMN transmigration, incubation with MALP-2 or with anti-mouse CD47 mAbs did not inhibit transfilter migration of TLR2(-/-) or MyD88(-/-)-deficient murine bone marrow-derived PMNs. Similarly, inhibition of MyD88 homodimerization reversed the attenuation of human PMN transmigration induced by MALP-2 or anti-human CD47 mAbs. Separate experiments demonstrated that CD47(-/-) murine bone marrow-derived PMNs exhibited 4-fold decreased sensitivity toward MALP-2. Collectively, these findings suggest that activation of CD47 signaling enhances PMN sensitivity toward TLR2 activation which, in turn, signals their arrival at a site of invasion and may facilitate antimicrobial function.
authors.affiliation: Epithelial Pathobiology Unit, Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA 30322, USA. achin@emory.edu
authors.forename: Alex C
authors.initials: AC
authors.lastname: Chin
authors.forename: Bénédicte
authors.initials: B
authors.lastname: Fournier
authors.forename: Eric J
authors.initials: EJ
authors.lastname: Peatman
authors.forename: Titus A
authors.initials: TA
authors.lastname: Reaves
authors.forename: Winston Y
authors.initials: WY
authors.lastname: Lee
authors.forename: Charles A
authors.initials: CA
authors.lastname: Parkos
mesh_terms: D000818:Animals; D001426:Bacterial Proteins / Q000502:physiology; D051928:CD47 Antigen / Q000502:physiology*; D002464:Cell Migration Inhibition / Q000276:immunology; D002634:Chemotaxis, Leukocyte / Q000276:immunology; D006801:Humans; D055666:Lipopeptides / Q000502:physiology; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D020556:Neutrophil Infiltration / Q000235:genetics / Q000276:immunology*; D009504:Neutrophils / Q000276:immunology* / Q000382:microbiology / Q000473:pathology; D020239:Receptor Cross-Talk / Q000276:immunology*; D015398:Signal Transduction / Q000276:immunology; D051195:Toll-Like Receptor 2 / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D051216:Toll-Like Receptor 6 / Q000502:physiology*
chemical_list: D001426:Bacterial Proteins; D051928:CD47 Antigen; C497894:CD47 protein, human; D055666:Lipopeptides; C493486:Tlr2 protein, mouse; C495369:Tlr6 protein, mouse; D051195:Toll-Like Receptor 2; D051216:Toll-Like Receptor 6; C106335:macrophage stimulatory lipopeptide 2